Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001026864 | SCV001189331 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001473813 | SCV001677974 | likely benign | not provided | 2023-10-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001473813 | SCV002765473 | uncertain significance | not provided | 2022-06-15 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Gene |
RCV000034104 | SCV000058034 | not provided | Somatotroph adenoma | no assertion provided | literature only |